Universal Quality Concerns: How Will Quality be Measured and Managed in a Global Marketplace?
Industry Compass 2.0 Landmark
Each Industry Compass 2.0 Landmark features a key strategic question confronting industry stakeholders across all sectors as they define and navigate the future. Understanding the multi-faceted implications of these questions can facilitate an enhanced approach to strategic planning in an uncertain environment.
Key Question: How will quality be measured and managed in a global marketplace?
- Can the FDA (or any regulatory body) keep pace with the complexities of new technologies, convergent solutions and provider dynamics?
- Will consumer/health plan demands for transparency of provider outcomes and product efficacy data help or hinder quality standards?
- What role should providers and life sciences companies play in setting quality standards?
- Should there be an ultimate arbiter of quality?
What is Industry Compass 2.0?
Produced by Deloitte LLP’s Health Sciences & Government Practice and Institute for the Future’s (IFTF) Health Horizons Program, the Industry Compass 2.0 is a visual guide designed to help you think about, plan for and navigate the future in an engaging and constructive way. The major elements of the Industry Compass 2.0 map – Drivers, Impact Zones, Trends, Signals, Hurdles, Landmarks and Artifacts – provide a framework for discussions about how the elements might interact and how your organization might respond to or even co-create the future.
As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.